-
Product Insights
Cypress Creek Hunter Solar PV Park
Cypress Creek Hunter Solar PV Park is a solar PV project located in Colorado, United States. The project is owned by DE Shaw Renewable Investments LLC; Torch Clean Energy LLC and is developed by Cypress Creek Solutions; Torch Clean Energy LLC. The project is currently under construction. Empower your strategies with our Cypress Creek Hunter Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will...
-
Product Insights
Hunter Valley Coal Power Plant I
Hunter Valley Coal Power Plant I is a thermal project located in New South Wales, Australia. The project is owned by Kaisun Holdings Ltd and others and is developed by Kaisun Holdings Ltd. The project is expected to come online in 2028. Empower your strategies with our Hunter Valley Coal Power Plant I report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to...
-
Product Insights
West Sussex Hunters Race Solar PV Park
West Sussex Hunters Race Solar PV Park is a solar PV project located in England, United Kingdom. The project is owned by Foresight Solar Fund Ltd and was developed by Hareon Solar Technology Co Ltd. The project came online in 2014. Empower your strategies with our West Sussex Hunters Race Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Adipose Tissue Derived Mesenchymal Stromal/Stem Cells in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Adipose Tissue Derived Mesenchymal Stromal/Stem Cells in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Adipose Tissue Derived Mesenchymal Stromal/Stem...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – 4D-150 in Wet (Neovascular / Exudative) Macular Degeneration
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - 4D-150 in Wet (Neovascular / Exudative) Macular Degeneration report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. 4D-150 in Wet (Neovascular / Exudative) Macular Degeneration...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DNL-310 in Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DNL-310 in Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.DNL-310 in Mucopolysaccharidosis II (MPS II) (Hunter Syndrome...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RGX-121 in Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RGX-121 in Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.RGX-121 in Mucopolysaccharidosis II (MPS II) (Hunter Syndrome...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pabinafusp alfa in Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pabinafusp alfa in Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Pabinafusp alfa in Mucopolysaccharidosis II (MPS II)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zimberelimab in Gastroesophageal (GE) Junction Carcinomas
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Zimberelimab in Gastroesophageal (GE) Junction Carcinomas Drug Details: Zimberelimab (Sepalizumab) is a human monoclonal monospecific antibody...
-
Thematic Analysis
Agriculture M&A Deals Q3 2023 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q3 2023 in the Agriculture Sector.